Page 1,831«..1020..1,8301,8311,8321,833..1,8401,850..»

Dennis Steindler, HNRCA – Video

Posted: March 13, 2015 at 1:40 pm


Dennis Steindler, HNRCA
Stem Cells, Avatars and Phytotherapeutics For Aging and Neurological Disease.

By: HNRCA

Go here to see the original:
Dennis Steindler, HNRCA - Video

Posted in Stem Cell Videos | Comments Off on Dennis Steindler, HNRCA – Video

GCSE Additional Science Biology Stem Cells – Video

Posted: March 13, 2015 at 1:40 pm


GCSE Additional Science Biology Stem Cells
Here #39;s the quiz for this video https://docs.google.com/forms/d/1KH-O26mDfXgQEiTIWMn7MUdgC5OCLLoURWvUdGSRBcI/viewform?usp=send_form.

By: ABS Additional Science Biology

View post:
GCSE Additional Science Biology Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on GCSE Additional Science Biology Stem Cells – Video

Nova Cells Institute Mexico successful stem cell treatments, 562-916-3410 – Video

Posted: March 13, 2015 at 1:40 pm


Nova Cells Institute Mexico successful stem cell treatments, 562-916-3410
Nova Cells Institute Mexico successful stem cell treatments, 562-916-3410 http://www.novacellsinstitute.com.

By: NCIM

Here is the original post:
Nova Cells Institute Mexico successful stem cell treatments, 562-916-3410 - Video

Posted in Stem Cell Treatments | Comments Off on Nova Cells Institute Mexico successful stem cell treatments, 562-916-3410 – Video

National Institute on Child Health & Human Development Stem Cell Research – Video

Posted: March 13, 2015 at 1:40 pm


National Institute on Child Health Human Development Stem Cell Research
Thomas Miller is a Post-Doc Fellow in the Section on Molecular Morphogenesis at the National Institute on Child Health Human Development. Thomas is trying ...

By: LabTV

The rest is here:
National Institute on Child Health & Human Development Stem Cell Research - Video

Posted in Stem Cell Research | Comments Off on National Institute on Child Health & Human Development Stem Cell Research – Video

WSCS 2014: NEW PATHS TO THE FINAL FRONTIER: ENABLING STEM CELL RESEARCH IN SPACE FOR LIFE ON EARTH – Video

Posted: March 13, 2015 at 1:40 pm


WSCS 2014: NEW PATHS TO THE FINAL FRONTIER: ENABLING STEM CELL RESEARCH IN SPACE FOR LIFE ON EARTH
SUPPORTED BY CASIS Moderator - Michael S. Roberts, PhD, Center for the Advancement of Science in Space, Inc. Speakers - Carl Gregory, PhD, Texas A M Institut...

By: worldstemcell

Go here to see the original:
WSCS 2014: NEW PATHS TO THE FINAL FRONTIER: ENABLING STEM CELL RESEARCH IN SPACE FOR LIFE ON EARTH - Video

Posted in Stem Cell Research | Comments Off on WSCS 2014: NEW PATHS TO THE FINAL FRONTIER: ENABLING STEM CELL RESEARCH IN SPACE FOR LIFE ON EARTH – Video

Stem Cell Therapies News – World Stem Cells, LLC

Posted: March 13, 2015 at 12:07 am

November 22, 2014

Stem Cell breakthrough!: World Stem Cell Institute a 501 c3 Non-Profit organized to perform stem research, educate the public, and patient Funding are on the threshold of a stem cell breakthrough!

Mr. Newcomer the CEO of World Stem Cell Institute http://worldstemcellinstitute.org/ have been studying and performing research on stem cells since 1962 after seeing a movie in a college genetics class which showed the development of a chick.

Read more October 11, 2014

Interview with Dr. Ernesto Gutierrez from the World Stem Cells Clinic by Healthcare Elsewhere show with John Cote on iTunes!

Dr. Gutierrez is the medical director and president of the World Stem Cells Clinic in Cancun, Mexico. The clinic was established in 2010 and treats numerous conditions including autism, multiple sclerosis, rheumatoid arthritis, lupus, chronic kidney disease, Charcot-Marie-Tooth disease (CMT) and Chronic Obstructive Pulmonary Disease (COPD). Dr. Gutierrez states that he uses the patients own stem cells to treat and heal their conditions. While he does not claim to cure these conditions, he states that the treatment intends to reverse some of the damage and control the progression of the condition.

Read more October 6, 2014

Educating Medical Professionals &Patients on Stem Cell Advancements with Dr. Ernesto Gutierrez

Dr. Ernesto Gutierrez, M.D. was interviewed recently for the Healthcare Elsewhere show with John Cote on iTunes! They discussed several things from patient experiences to the latest advances in cellular therapies now available for our patients.

Read more September 29, 2014

See the article here:
Stem Cell Therapies News - World Stem Cells, LLC

Posted in Nevada Stem Cells | Comments Off on Stem Cell Therapies News – World Stem Cells, LLC

Super-resolution microscopes reveal the link between genome packaging and cell pluripotency

Posted: March 13, 2015 at 12:07 am

12 hours ago A comparison between an image of the nucleus of a cell obtained with the STORM technique (left yellow image) and one obtained with conventional microscopes (right blue image). The STORM technique shows its power to resolve the genome structure at the nano-scale. Credit: CRG/ICFO

A study using Super-resolution microscopy reveals that our genome is not regularly packaged and links these packaging differences to stem cell state. A multidisciplinary approach allowed scientists to view and even count, for the first time, the smallest units for packaging our genome. This study has brought together biologists and physicists from the Centre for Genomic Regulation and the Institute of Photonic Sciences, both in Barcelona.

In 1953 Watson and Crick first published the discovery of the double helix structure of the DNA. They were able to visualize the DNA structure by means of X-Ray diffraction. Techniques, such as electron microscopy, allowed scientists to identify nucleosomes, the first and most basic level of chromosome organisation. Until now it was known that our DNA is packaged by regular repeating units of those nucleosomes throughout the genome giving rise to chromatin. However, due to the lack of suitable techniques and instruments, the chromatin organisation inside a cell nucleus could not be observed in a non-invasive way with the sufficient resolution. Now, for the first time, a group of scientists at the CRG and ICFO in Barcelona, have been able to visualise and even count the smallest units which, packaged together, form our genome. This study was possible thanks to the use of super-resolution microscopy, a new cutting-edge optical technique that received the Nobel Prize in Chemistry in 2014. In combination with innovative quantitative approaches and numerical simulations, they were also able to define the genome architecture at the nano-scale. Most importantly, they found that the nucleosomes are assembled in irregular groups across the chromatin and nucleosome-free-DNA regions separate these groups.

Biologists and physicists have been working together to take a step forward in chromatin fibre observations and studies. "By using the STORM technique, a new super-resolution microscopy method, we have been able to view and even count nucleosomes across the chromatin fibers and determine their organisation. STORM overcomes the diffraction limit that normally restricts the spatial resolution of conventional microscopes and enables us to precisely define the chromatin fibre structure", states Prof. Melike Lakadamyali, group leader at ICFO.

This video is not supported by your browser at this time.

This enabling technique allowed the researchers to go deeper and, by comparing stem cells to differentiated cells (specialised cells that have already acquired their role), they observed key differences in the chromatin fibre architectures of both cells. Pia Cosma, group leader and ICREA research professor at the CRG explains, "We found that stem cells have a different chromatin structure than somatic (specialised) cells. At the same time, this difference correlates with the level of pluripotency. The more pluripotent a cell is, the less dense is its packaging. It gives us new clues to understand the stem cells functioning and their genomic structure, which will be helpful for example, in studying cell reprogramming".

What scientists have found is that DNA is not regularly packaged with nucleosomes, instead nucleosomes are assembled in groups of varying sizes, called "nucleosome clutches" -because of their similarity to egg clutches-. They found that pluripotent stem cells have, on average, clutches with less density of nucleosomes. In addition, clutch size is related to the pluripotency potential of stem cells, meaning that the more pluripotent a cell is, the less nucleosomes are included in its clutches.

Even though all the cells in our body have the same genetic information, they are not expressing all the genes at the same time. So, when a cell specialises, some of the DNA regions are silenced or less accessible to the molecule that reads the genome: the RNA polymerase. Depending on the specialisation of the cells, different levels of DNA packaging will occur. This new work published in the prestigious journal Cell, establishes a new understanding of how the chromatin fibre is assembled and packaged forming a specific DNA structure in every cell.

This research definitively contributes to the understanding of a novel feature of stem cells and their DNA structure, which is important for maintaining an induced pluripotent state. A joint patent has been filed by ICFO and CRG, who are now exploring business opportunities for marketing the classification of "stemness" state of cells, ie, their degree of pluripotency. This technique could determine with single cell sensitivity the pluripotency potential of stem cells, thus having the capacity of becoming a standard method of quality control of stem or pluripotent cells before their use in cell therapy or research in biomedicine.

Explore further: New protagonist in cell reprogramming discovered

Continue reading here:
Super-resolution microscopes reveal the link between genome packaging and cell pluripotency

Posted in Nebraska Stem Cells | Comments Off on Super-resolution microscopes reveal the link between genome packaging and cell pluripotency

Bioelectricity Plays Key Role in Brain Development & Repair

Posted: March 13, 2015 at 12:06 am

Released: 9-Mar-2015 10:05 AM EDT Embargo expired: 10-Mar-2015 5:00 PM EDT Source Newsroom: Tufts University Contact Information

Available for logged-in reporters only

Newswise MEDFORD/SOMERVILLE, Mass. (March 11, 2015) -- Research reported today by Tufts University biologists shows for the first time that bioelectrical signals among cells control and instruct embryonic brain development and manipulating these signals can repair genetic defects and induce development of healthy brain tissue in locations where it would not ordinarily grow.

The research reveals that bioelectric signaling regulates the activity of two cell reprogramming factors (proteins that can turn adult cells into stem cells), which for the first time were analyzed in Xenopus laevis embryos, which share many evolutionary traits with humans. Results appear in the March 11, 2015, edition of the Journal of Neuroscience.

"Weve found that cells communicate, even across long distances in the embryo, using bioelectrical signals, and they use this information to know where to form a brain and how big that brain should be," says the papers corresponding author Michael Levin, Ph.D., who holds the Vannevar Bush Chair in biology and directs the Center for Regenerative and Developmental Biology in the School of Arts and Sciences at Tufts. "The signals are not just necessary for normal development; they are instructive."

Levin uses an analogy to a computer. "Bioelectrical signals are not simply the switch that turns the computer on or off, passively allowing it to perform its functions. They actually carry important information, functioning like the software that enables the computer to carry out complex activities."

These bioelectric signals are implemented by changes in the voltage difference across cell membranes called the cellular resting potential -- and the patterns of differential voltages across anatomical regions.

Bioelectric signaling involves different cell types, including mature somatic cells and stem cells. Prior work in the Levin lab revealed roles for bioelectric gradients in eye, limb and visceral organ patterning, and the new paper found that natural embryonic voltage gradients instruct the formation of the brain.

Overriding Genetic Defects "This latest research also demonstrated molecular techniques for 'hijacking' this bioelectric communication to force the body to make new brain tissue at other locations and to fix genetic defects that cause brain malformation," says Levin. "This means we may be able to induce growth of new brain tissue to address birth defects or brain injury, which is very exciting for regenerative medicine."

A case in point is the Notch signaling pathway, a protein signaling system that plays a role in neural cell growth and differentiation in mammals and most other multicellular organisms. Defects in Notch signaling disrupt brain development and are also associated with disorders such as T-cell acute lymphoblastic leukemia and multiple sclerosis. The research team found that using molecular techniques to force proper bioelectrical states in cells enabled them to override the defects induced by Notch malfunction, resulting in a much more normal brain despite a genetically-defective Notch protein.

Read more here:
Bioelectricity Plays Key Role in Brain Development & Repair

Posted in Minnesota Stem Cells | Comments Off on Bioelectricity Plays Key Role in Brain Development & Repair

Why Are Drugs So Expensive? One Reason: Scientists Can't Reproduce Each Other's Work

Posted: March 13, 2015 at 12:02 am

Dr. Moshe Pritsker ran up against one of the most aggravating problems in science as he embarked on his doctoral research in molecular biology at Princeton University. He was trying to reproduce an experiment on embryonic stem cells that he had read about in a journal. But no matter how hard he tried, he could not replicate the original experiments findings.

After several colleagues also came up short, he hopped on a flight and spent two weeks working alongside the scientist who completed the original work. There in the lab, Pritsker was able to witness the researcher's methods firsthand and eventually learned enough to replicate the findings, but he was left feeling frustrated by what the ordeal meant for his field.

The whole premise of science is that it's reproducible, he says. Science is not a science if it's not reproducible.

Its an unglamorous truth of scientific inquiry -- researchers consistently fail to reproduce each others experiments. While any scientist should, in theory, be able to replicate the findings of another based on the scientific method, the reality is that most results are not nearly so reliable.Their frequent failures slow the pace of innovation and ultimately cost researchers at universities, government agencies and companies time and money.

Pharmaceutical companies in particular are worried that this challenge will continue to push their costs, and therefore prices, to ever-higher levels. Drug research has grown increasingly less efficient in recent decades andDr. Ulo Palm, chairman of the research committee for food and drugs at the American Society for Quality, suggests that a lack of reproducibility is at least partly to blame. The number of Food and Drug Administration-approved drugs the pharmaceutical industry pumps out for every billion dollars it spends on research and development has dropped by 50 percent every nine years since the 1950s in a trend known as Erooms Law. Today, it costs $2.6 billion to usher the average drug to market, which is more than double the cost from a decade ago, according to a recent analysis from the Center for the Study of Drug Development at Tufts University.

Meanwhile, the amount of medical literature generated by researchers in the field is doubling every five years.

We know so much about modern biology but somehow, we don't seem to be able to turn it into real treatments because our resources are wasted on trying to reproduce work that is faulty in the first place, Palm says.

Starting in 2002, scientists at Amgen tried to replicate 53 landmark scientific studies. A decade later, they published a paper noting they could only confirm the findings of six. Researchers at Bayer run up against this problem in roughly two-thirds of the studies that they try to validate when seeking new treatments for cancer and cardiovascular disease.

If you look at whats happened to human health over the last couple of decades, researchers have made enormous improvements -- that's not in dispute, C. Glenn Begley, a former Amgen scientist who published a record of the companys attempts to replicate landmark research, says. What's concerning to me is that we could have made so much more progress. Its that opportunity cost that is frankly impossible to quantify.

Palm has also confronted the issue himself. In the mid-1980s, he failed to replicate an experiment having to do with kidney physiology during his doctoral research and later, while working for Novartis, he assumed responsibility for controlling the quality of the in-house experiments and improving the rate of reproducibility -- a position created to make research spending more efficient.

See original here:
Why Are Drugs So Expensive? One Reason: Scientists Can't Reproduce Each Other's Work

Posted in Washington Stem Cells | Comments Off on Why Are Drugs So Expensive? One Reason: Scientists Can't Reproduce Each Other's Work

Neuralstem Stock Plunges After Latest Study on ALS Drug

Posted: March 12, 2015 at 11:54 pm

GERMANTOWN, Md. (TheStreet) -- Neuralstem (CUR - Get Report) is providing an overly optimistic picture about its surgical stem-cell therapy for amyotrophic lateral sclerosis (ALS), the degenerative and fatal nerve disease.

Instead of disclosing the results from all 15 ALS patients enrolled in Neuralstem's phase II study of NSI-566, the company decided to only release a comparison between the patients who responded and those who didn't respond. Of course, the seven responders in the study showed more stabilization or improvements in muscle function compared with the eight patients deemed non-responders.

The scientific term for this conclusion is, "Duh."

When you work backwards and do some simple math on the muscle performance of all 15 ALS patients in the Neuralstem study, the results aren't very encouraging. Neuralstem chose to stay mum on this more customary analysis.

Neuralstem shares are down 14% to $3.21 in Thursday trading.

Follow this link:
Neuralstem Stock Plunges After Latest Study on ALS Drug

Posted in Stem Cell Therapy | Comments Off on Neuralstem Stock Plunges After Latest Study on ALS Drug

Page 1,831«..1020..1,8301,8311,8321,833..1,8401,850..»